Related Experiment Video
Updated: Oct 9, 2025

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness
Published on: May 3, 2018
The COSEVAST Study Outcome: Evidence of COVID-19 Severity Proportionate to Surge in Arterial Stiffness
Neeraj Kumar1, Sanjeev Kumar2, Abhyuday Kumar3
1Department of Trauma and Emergency, All India Institute of Medical Sciences, Patna, Bihar, India.
Insights
COVID-19 infection causes significant arterial stiffness, a marker of disease severity. This study demonstrates that arterial stiffness increases with COVID-19 severity, indicating functional arterial damage.
Area of Science:
- Cardiovascular Medicine
- Infectious Diseases
- Medical Diagnostics
Background:
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) impacts the cardiovascular system, primarily through endothelial cell infection, inflammation, and damage.
- Empirical evidence for functional compromise of arterial walls in SARS-CoV-2 infection was previously lacking.
Purpose of the Study:
- To investigate functional arterial damage in coronavirus disease 2019 (COVID-19).
- To establish noninvasive arterial stiffness measurements as an independent marker for COVID-19 severity.
Main Methods:
- Arterial stiffness was assessed in 64 COVID-19 patients across mild, moderate, and severe categories based on NIH criteria.
- Key parameters measured included carotid-femoral pulse wave velocity (cfPWV), age-normalized cfPWV (ANI_cfPWV), age-normalized aortic augmentation pressure (ANI_AugP), and heart rate-normalized augmentation index (HRN_AIx).
- Statistical analysis corrected for significant confounding factors.
Main Results:
- Moderate and severe COVID-19 patients exhibited significantly elevated arterial stiffness compared to mild cases.
- Mild patients had cfPWV of 829.1 ± 139.2 cm/s, significantly lower than moderate (1067 ± 152.5 cm/s) and severe (1416 ± 253.9 cm/s) groups (p <0.0001).
- ANI_cfPWV was significantly higher in moderate and severe groups compared to mild, with results remaining consistent after confounding factor correction.
Conclusions:
- This study confirms functional arterial deterioration in COVID-19 patients.
- Arterial stiffness is directly proportional to the severity of COVID-19.
Background:
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection affects the cardiovascular system at many levels. It initially infects endothelial cells, inducing marked endothelial damage and inflammation. However, there was no empirical evidence of functional compromise of arterial walls.
Aims And Objective:
Our primary objective was to study functional arterial damage in coronavirus disease 2019 (COVID-19) and establish the noninvasive measurement of arterial stiffness as an independent marker of disease severity.
Materials And Methods:
We recorded the arterial stiffness of 23 mild, 21 moderate, and 20 severe COVID-19 patients grouped on the latest National Institute of Health (NIH) severity criteria. We observed arterial stiffness of COVID-19 patients with standard parameters like noninvasive estimated carotid-femoral pulse wave velocity (cfPWV), age-normalized increase in cfPWV (ANI_cfPWV), age-normalized increase in aortic augmentation pressure (ANI_AugP), and heart rate-normalized augmentation index (HRN_ AIx). All the parameters were also corrected for statistically significant confounding factors.
Results:
Moderate and severe COVID-19 patients have extremely significantly elevated arterial stiffness than mild patients. In mild patients, cfPWV (829.1 ± 139.2 cm/second) was significantly lower than both moderate (1067 ± 152.5 cm/second, p <0.0001) and severe (1416 ± 253.9 cm/second, p <0.0001) patients. ANI_cfPWV in moderate and severe patients was significantly higher than mild patients (mild: 101.2 ± 126.1 cm/second; moderate: 279 ± 114.4 cm/second; severe: 580.1 ± 216.4 cm/second; intergroup p <0.0001). The results even after correction for significant confounding factors did not show any considerable change in the increasing trend of arterial stiffness.
Conclusion:
This study establishes the functional deterioration of arteries in proportion to the severity of COVID-19.
How To Cite This Article:
Kumar N, Kumar S, Kumar A, Bhushan D, Kumar A, Kumar A, et al. The COSEVAST Study Outcome: Evidence of COVID-19 Severity Proportionate to Surge in Arterial Stiffness. Indian J Crit Care Med 2021;25(10):1113-1119.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease III: Clinical Manifestations
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Assessment of blood pressure in brachial artery(two-step method)
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Acute Coronary Syndrome III: Diagnostic Studies

